Drug delivery neural stimulation device for treatment of cardiovascular disorders

• US 6,178,349 B1
• Filed: 04/15/1999
• Issued: 01/23/2001
• Est. Priority Date: 04/15/1999
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Kieval, Robert S.
• Primary Examiner(s): Jastrzab, Jeffrey R.
• Application Number:
  US09/292,507
• Time in Patent Office: 649 Days
• Field of Search: 607/115-118, 607/120, 607/3, 600/372, 600/373, 600/377, 604/93, 604/20, 604/113, 604/118, 604/131, 604/132, 604/141, 604/151, 604/181, 604/65-67, 604/264
• US Class Current: 607/3
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362

Abstract

An implantable medical device for treatment of cardiovascular disorders by stimulating a selective nerve, the device including an implantable pulse generator, an implantable electrode body and a reservoir. The electrode body includes an electrode electrically connected to the pulse generator. Further, the electrode body is configured to sustain long-term contact between the electrode and the nerve. The reservoir maintains a nerve stimulating drug, such as a veratrum alkaloid, and defines a delivery surface through which the drug is released from the reservoir. Finally, the reservoir is operatively associated with the electrode body to deliver the nerve stimulating drug directly to the nerve. During use, the electrode and the delivered drug stimulate the nerve to effect control over the cardiovascular system of the patient.

Claims

1. An implantable medical device for enhanced stimulation of a nerve to treat cardiovascular disorders, the device comprising:

an implantable pulse generator;

an implantable electrode body including an electrode electrically connected to the pulse generator, the electrode body configured to sustain long-term contact between the electrode and the nerve; and

a reservoir maintaining a nerve stimulating drug and defining a delivery surface through which the nerve stimulating drug is released from the reservoir;

wherein the reservoir is operatively controlled by the implantable pulse generator to deliver the nerve stimulating drug directly to the nerve.

2. The device of claim 1, wherein the nerve stimulating drug is a veratrum alkaloid.

3. The device of claim 2, wherein the veratrum alkaloid is selected from the group consisting of protoveratrine and veratridine.

4. The device of claim 1, wherein the reservoir is a polymer matrix containing the nerve stimulating drug.

5. The device of claim 4, wherein the polymer matrix is impregnated into the electrode body.

6. The device of claim 1, wherein the reservoir includes a container having at least one opening defining the delivery surface.

7. The device of claim 1, wherein the delivery surface is a microporous tip.

8. The device of claim 1, wherein the reservoir is associated with the electrode body such that upon final implant of the electrode body, the delivery surface is in close proximity to the nerve.

9. The device of claim 1, further comprising:

regulating means for regulating release of the nerve stimulating drug from the reservoir in response to physiological feedback.

10. The device of claim 9, wherein the regulating means includes an electrophoretic mechanism formed with the reservoir for initiating delivery of veratrum alkaloid as the nerve stimulating drug.

11. The device of claim 9, wherein the reservoir is configured to deliver the nerve stimulating drug in response to a temperature rise, the regulating means including a heating element contacting the reservoir and connected to the pulse generator for selectively energizing the heating element.

12. The device of claim 9, wherein the regulating means is configured to prompt delivery of the nerve stimulating drug upon activation by the pulse generator, the device further including:

a triggering device electrically connected to the pulse generator, the triggering device configured to selectively provide an activation signal from the pulse generator to the regulating means.

13. The device of claim 12, further comprising:

a cardiovascular sensor associated with the heart of the patient for monitoring heart activity and for providing a signal indicative of abnormal cardiovascular activity.

14. The device of claim 13, wherein the triggering device is configured to provide the activation signal in response to the signal indicative of abnormal cardiovascular activity.

15. The device of claim 9, wherein the reservoir is configured to provide a variable delivery rate of the nerve stimulating drug from the reservoir.

16. The device of claim 15, wherein the device further includes a delivery rate circuit for determining a desired delivery rate of the nerve stimulating drug from the reservoir.

17. An improved nerve stimulation system for treatment of cardiovascular disorders including an electrode body having an electrode connected to an implantable pulse generator, the electrode body being configured for implantation within a patient so as to establish long-term contact between the electrode and a nerve, the improvement comprising:

a reservoir maintaining a nerve stimulating drug, the reservoir being operatively associated with the electrode body and configured to deliver the drug directly onto the nerve as controlled by electrical signals provided by the implantable pulse generator.

18. The improvement of claim 17, wherein the nerve stimulating drug is a veratrum alkaloid.

19. The improvement of claim 18, wherein the veratrum alkaloid is selected from the group consisting of protoveratrine and veratridine.

20. The improvement of claim 17, wherein the reservoir is configured to allow constant elution of the nerve stimulating drug upon implant.

21. The improvement of claim 17, wherein the system includes at least one sensor for sensing physiological signals, and the reservoir is configured to control delivery of the nerve stimulating drug based on physiological feedback provided by the at least one sensor.

22. The improvement of claim 21, wherein the nerve stimulating drug is formulated to elute a drug in response to a temperature rise, the reservoir including a heating element electrically connected to the pulse generator for causing a temperature rise.

23. The improvement of claim 21, wherein the reservoir includes a container maintaining the nerve stimulating drug in liquid form and a positive displacement mechanism, the positive displacement mechanism configured to selectively force the nerve stimulating drug from the container.

24. A method for improved neural stimulation to treat cardiovascular disorders, the method comprising:

providing a control device;

stimulating a selected nerve with an electrode activated by the control device; and

stimulating the nerve with a drug delivered from a reservoir maintaining the drug, the reservoir being implanted in close proximity to the nerve and activated to deliver drugs by the control device.

25. The method of claim 24, wherein stimulating the nerve with a drug includes delivering a veratrum alkaloid to the nerve.

26. The method of claim 24, further including:

associating the electrode and the reservoir with a carotid sinus nerve.

27. The method of claim 24, wherein the nerve is periodically stimulated by the electrode and the drug.

28. The method of claim 24, wherein the reservoir is configured to selectively deliver the drug, the method further comprising:

correlating the delivery of the drug with activation of the electrode to generate a nerve stimulation therapy.

29. The method of claim 28, wherein correlating delivery of the drug includes:

establishing an activation cycle time for the electrode;

delivering the drug;

determining a level of nerve stimulation caused by the drug; and

altering the activation cycle time for the electrode based upon the level of nerve stimulation caused by the drug.

30. The method of claim 24, wherein the reservoir is configured to selectively deliver the drug, the method further comprising:

controlling delivery of the drug from the reservoir based on cardiovascular feedback information received by the control device.

31. The method of claim 30, wherein the control device includes a triggering device connected to the reservoir, and further wherein controlling delivery of the drug includes:

signaling the reservoir with the triggering device to prompt delivery of the drug.

32. The method of claim 30, wherein a cardiovascular sensor is provided for sensing abnormal cardiovascular activities of the patient and generating a signal indicative of an abnormal cardiovascular activity, and further wherein controlling delivery of the drug includes:

activating the reservoir in response to the signal.

33. The method of claim 30, wherein the reservoir is configured to provide a variable delivery rate, and further wherein controlling delivery of the drug includes:

determining a desired rate of delivery of the drug; and

controlling the reservoir to deliver the drug at the desired delivery rate.